Form 4 for ANRO Alto Neuroscience, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-02-06 · accession 0000950170-24-026885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +674.7K | 674.7K | New | — |
| D | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +251.9K | 251.9K | New | — |
| DM | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | -850.6K | 0 | -100% | — |
| DMI | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | -1.48M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | C | A | 674,658 | — | 674,658 | I | — | — | (F1) In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis. |
| 2 | Common | Common Stock | 2024-02-06 | C | A | 251,881 | — | 251,881 | D By Apeiron Presight Capital Fund II, L.P.( | — | — | (F1) In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis. (F2) The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities. (F3) The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron Investment Group Ltd. ("Apeiron") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities. |
| 3 | Derivative | Series A Preferred Stock | 2024-02-06 | C | D | 406,072 | — | 0 | D By Apeiron Presight Capital Fund II, L.P. | — · — to — | 182,577 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis. (F2) The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities. (F3) The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron Investment Group Ltd. ("Apeiron") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities. |
| 4 | Derivative | Series B Preferred Stock | 2024-02-06 | C | D | 416,665 | — | 0 | I | — · — to — | 196,299 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis. (F5) In connection with the closing of the Issuer's initial public offering, each share of Series B Preferred automatically converted into common stock on a 2.1226069 for 1 basis. |
| 5 | Derivative | Warrants to Purchase Series A Preferred Stock | 2024-02-06 | C | D | 444,561 | — | 0 | D By Apeiron Presight Capital Fund II, L.P. | — · — to — | 69,304 Common Stock | (F4) In connection with the closing of the Issuer's initial public offering, the Warrants were exercised on a cashless basis into shares of Series A Preferred Stock, which were automatically converted into shares of Common Stock on a 2.2241 for 1 basis. (F2) The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities. (F3) The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron Investment Group Ltd. ("Apeiron") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities. |
| 6 | Derivative | Series A Preferred Stock | 2024-02-06 | C | D | 1,063,918 | — | 0 | I | — · — to — | 478,359 Common Stock | (F1) In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis. |